New cream shows promise for rare, severe skin condition
NCT ID NCT05211830
First seen Jan 05, 2026 · Last updated May 17, 2026 · Updated 18 times
Summary
This study tested a cream called SXR1096 in 9 people with Netherton syndrome, a rare genetic skin disease that causes redness, scaling, and itching. The cream aims to block certain enzymes that drive the disease. Participants applied the cream to some skin areas and a placebo to others for one month to compare safety and effectiveness.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NETHERTON SYNDROME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Karolinska Hospital, Huddinge
Stockholm, Sweden
-
Medical University Innsbruck, Tirol Kliniken
Innsbruck, Austria
-
Necker Hospital
Paris, France
-
Saint Louis Hospital
Paris, 75010, France
-
University of Freiburg
Freiburg im Breisgau, Germany
Conditions
Explore the condition pages connected to this study.